Skip to main content
Top
Published in: Annals of Hematology 9/2016

01-09-2016 | Original Article

Changing patterns in the Epstein-Barr virus (EBV)and Hodgkin lymphoma association in Tunisia

Authors: Myriam Ben Dhiab, Sonia Ziadi, Hanene Saad, Teheni Louhichi, Mounir Trimeche

Published in: Annals of Hematology | Issue 9/2016

Login to get access

Abstract

We compared the features of the Epstein-Barr virus (EBV) and Hodgkin lymphoma (HL) association in Tunisia in two periods of time, 1991–2001 (111 cases) and 2002–2012 (122 cases). The investigation of the EBV status by EBER in situ hybridization showed a significant decrease in the prevalence of EBV-positive HL from 69.3 % for the period 1991–2001 to 40.1 % for the 2002–2012 period (p = 0.00001). EBV positivity has decreased in all age groups but was more pronounced among young patients, in the 15–24-year age group (46.1 vs 10.3 %, p = 0.003), in the 25–34-year age group (56.2 vs 25 %, p = 0.04), and among children (88.4 vs 59.2 %, p = 0.01). This decrease in EBV-positive HL over time contrasted with a remarkable increase in EBV-negative HL in young adults aged 15–34 years (51.2 vs 83 %; p = 0.001), especially among women (59.1 vs 91.2 %; p = 0.01). The decrease in EBV-positive HL over time concerns particularly the nodular sclerosis histological subtype (69.2 vs 31.6 %, p = 0.000001). These results indicate that the epidemiology of HL and its association with EBV are changing over time, with a trend toward a Western profile, and point toward the emergence of other environmental causative factors, especially among young women, which remain to be identified.
Literature
1.
go back to reference Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, World Health Organization Classification of Tumours, Lyon Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, World Health Organization Classification of Tumours, Lyon
2.
go back to reference MacMahon B (1966) Epidemiology of Hodgkin’s disease. Cancer Res 26:1189–1201PubMed MacMahon B (1966) Epidemiology of Hodgkin’s disease. Cancer Res 26:1189–1201PubMed
3.
go back to reference Cole P, MacMahon B, Aisenberg A (1968) Mortality from Hodgkin’s disease in the United States. Evidence for the multiple-aetiology hypothesis. Lancet 2:1371–1376CrossRefPubMed Cole P, MacMahon B, Aisenberg A (1968) Mortality from Hodgkin’s disease in the United States. Evidence for the multiple-aetiology hypothesis. Lancet 2:1371–1376CrossRefPubMed
4.
go back to reference Correa P, O’Conor GT (1971) Epidemiologic patterns of Hodgkin’s disease. Int J Cancer 8:192–201CrossRefPubMed Correa P, O’Conor GT (1971) Epidemiologic patterns of Hodgkin’s disease. Int J Cancer 8:192–201CrossRefPubMed
5.
go back to reference Harris NL (1998) The many faces of Hodgkin’s disease around the world: what have we learned from its pathology? Ann Oncol 9:45–56CrossRef Harris NL (1998) The many faces of Hodgkin’s disease around the world: what have we learned from its pathology? Ann Oncol 9:45–56CrossRef
6.
go back to reference Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J (1987) Epstein-Barr viral DNA in tissues of Hodgkin’s disease. Am J Pathol 129:86–91PubMedPubMedCentral Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J (1987) Epstein-Barr viral DNA in tissues of Hodgkin’s disease. Am J Pathol 129:86–91PubMedPubMedCentral
7.
go back to reference Jarrett RF, Armstrong AA, Alexander E (1996) Epidemiology of EBV and Hodgkin’s lymphoma. Ann Oncol 7:5–10CrossRefPubMed Jarrett RF, Armstrong AA, Alexander E (1996) Epidemiology of EBV and Hodgkin’s lymphoma. Ann Oncol 7:5–10CrossRefPubMed
8.
go back to reference Glaser SL, Jarrett RF (1996) The epidemiology of Hodgkin’s disease. Bailliere Clin Haematol 9:401–416CrossRef Glaser SL, Jarrett RF (1996) The epidemiology of Hodgkin’s disease. Bailliere Clin Haematol 9:401–416CrossRef
9.
go back to reference Glaser SL, Lin RJ, Stewart SL, Ambinder R, Brousset RF, Pallesen G, Gulley ML, Khan G, O’Grady J, Hummel M, Preciado MV, Knecht H, Chan JK, Claviez A (1997) Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data. Int J Cancer 70:375–382CrossRefPubMed Glaser SL, Lin RJ, Stewart SL, Ambinder R, Brousset RF, Pallesen G, Gulley ML, Khan G, O’Grady J, Hummel M, Preciado MV, Knecht H, Chan JK, Claviez A (1997) Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data. Int J Cancer 70:375–382CrossRefPubMed
10.
go back to reference Gutensohn N, Cole P (1981) Childhood social environment and Hodgkin’s disease. N Engl J Med 304:135–140CrossRefPubMed Gutensohn N, Cole P (1981) Childhood social environment and Hodgkin’s disease. N Engl J Med 304:135–140CrossRefPubMed
11.
go back to reference Au WY, Gascoyne RD, Gallagher RE, Le N, Klasa RD, Liang RHS, Choy C, Foo W, Connors JM (2004) Hodgkin’s lymphoma in Chinese migrants to British Columbia: a 25-year survey. Ann Oncol 15:626–630CrossRefPubMed Au WY, Gascoyne RD, Gallagher RE, Le N, Klasa RD, Liang RHS, Choy C, Foo W, Connors JM (2004) Hodgkin’s lymphoma in Chinese migrants to British Columbia: a 25-year survey. Ann Oncol 15:626–630CrossRefPubMed
12.
go back to reference Varghese C, Barrett JH, Johnston C, Shires M, Rider L, Forman D (1996) High risk of lymphomas in children of Asian origin: ethnicity or confounding by socioeconomic status? Br J Cancer 74:1503–1505CrossRefPubMedPubMedCentral Varghese C, Barrett JH, Johnston C, Shires M, Rider L, Forman D (1996) High risk of lymphomas in children of Asian origin: ethnicity or confounding by socioeconomic status? Br J Cancer 74:1503–1505CrossRefPubMedPubMedCentral
13.
go back to reference Takeuchi K, Morishita Y, Fukayama M, Mori S (2001) Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin’s disease in Tokyo: trend between 1955 and 1999. Br J Haematol 11:429–431CrossRef Takeuchi K, Morishita Y, Fukayama M, Mori S (2001) Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin’s disease in Tokyo: trend between 1955 and 1999. Br J Haematol 11:429–431CrossRef
14.
go back to reference Chang KC, Chen PC, Jones D, Su IJ (2008) Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 99:345–349CrossRefPubMed Chang KC, Chen PC, Jones D, Su IJ (2008) Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 99:345–349CrossRefPubMed
15.
go back to reference Koh YW, Kang HJ, Yoon DH, Suh C, Kim JE, Kim CW, Huh J (2013) Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea. Ann Hematol 92:1653–1660CrossRefPubMed Koh YW, Kang HJ, Yoon DH, Suh C, Kim JE, Kim CW, Huh J (2013) Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea. Ann Hematol 92:1653–1660CrossRefPubMed
16.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers CD, and Parkin D (2014) GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; Year. Available at: http://globocan.iarc.fr.. Last accessed 09/01/2014. Ferlay J, Shin HR, Bray F, Forman D, Mathers CD, and Parkin D (2014) GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; Year. Available at: http://​globocan.​iarc.​fr.. Last accessed 09/01/2014.
17.
go back to reference Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF (1998) Epstein-Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis. Leukemia 12:1272–1276CrossRefPubMed Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF (1998) Epstein-Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis. Leukemia 12:1272–1276CrossRefPubMed
18.
go back to reference Wilson KS, Gallagher A, Freeland JM, Shield LA, Jarrett RF (2006) Viruses and Hodgkin lymphoma: no evidence of polyomavirus genomes in tumor biopsies. Leuk Lymphoma 47:1315–1321CrossRefPubMed Wilson KS, Gallagher A, Freeland JM, Shield LA, Jarrett RF (2006) Viruses and Hodgkin lymphoma: no evidence of polyomavirus genomes in tumor biopsies. Leuk Lymphoma 47:1315–1321CrossRefPubMed
19.
go back to reference Armstrong AA, Shield L, Gallagher A, Jarrett RF (1998) Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin’s disease. Br J Cancer 77:1045–1047CrossRefPubMedPubMedCentral Armstrong AA, Shield L, Gallagher A, Jarrett RF (1998) Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin’s disease. Br J Cancer 77:1045–1047CrossRefPubMedPubMedCentral
20.
go back to reference Secchiero P, Bonino LD, Lusso P, Abele MC, Reato G, Kerim S, Palestro G, Zauli G, Valente G (1998) Human herpesvirus type 7 in Hodgkin’s disease. Br J Haematol 101:492–499CrossRefPubMed Secchiero P, Bonino LD, Lusso P, Abele MC, Reato G, Kerim S, Palestro G, Zauli G, Valente G (1998) Human herpesvirus type 7 in Hodgkin’s disease. Br J Haematol 101:492–499CrossRefPubMed
21.
go back to reference Berneman ZN, Torelli G, Luppi M, Jarrett RF (1998) Absence of a directly causative role for human herpesvirus 7 in human lymphoma and a review of human herpesvirus 6 in human malignancy. Ann Hematol 77:275–278CrossRefPubMed Berneman ZN, Torelli G, Luppi M, Jarrett RF (1998) Absence of a directly causative role for human herpesvirus 7 in human lymphoma and a review of human herpesvirus 6 in human malignancy. Ann Hematol 77:275–278CrossRefPubMed
22.
go back to reference Cartwright RA, Watkins G (2004) Epidemiology of Hodgkin’s disease: a review. Hematol Oncol 22:11–26CrossRefPubMed Cartwright RA, Watkins G (2004) Epidemiology of Hodgkin’s disease: a review. Hematol Oncol 22:11–26CrossRefPubMed
23.
go back to reference Olsson H, Olsson ML, Ranstam J (1990) Late age at first full-term pregnancy as a risk factor for women with malignant lymphoma. Neoplasma 37:185–190PubMed Olsson H, Olsson ML, Ranstam J (1990) Late age at first full-term pregnancy as a risk factor for women with malignant lymphoma. Neoplasma 37:185–190PubMed
24.
go back to reference Knecht H, Berger C, Rothenberger S, Odermatt BF, Brousset P (2001) The role of Epstein–Barr virus in neoplastic transformation. Oncology 60:289–302CrossRefPubMed Knecht H, Berger C, Rothenberger S, Odermatt BF, Brousset P (2001) The role of Epstein–Barr virus in neoplastic transformation. Oncology 60:289–302CrossRefPubMed
25.
go back to reference Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein–Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328–1337CrossRefPubMed Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein–Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328–1337CrossRefPubMed
26.
go back to reference Kuppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann ML (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 91:10962–10966CrossRefPubMedPubMedCentral Kuppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann ML (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 91:10962–10966CrossRefPubMedPubMedCentral
27.
go back to reference Küppers R, Rajewsky K (1998) The origin of Hodgkin and Reed/Sternberg cells in Hodgkin’s disease. Annu Rev Immunol 16:471–493CrossRefPubMed Küppers R, Rajewsky K (1998) The origin of Hodgkin and Reed/Sternberg cells in Hodgkin’s disease. Annu Rev Immunol 16:471–493CrossRefPubMed
28.
go back to reference Asso-Bonnet M, Feuillard J, Ferreira V, Bissières P, Tarantino N, Körner M, Raphael M (1998) Relationship between IkBα constitutive expression, TNFα synthesis, and apoptosis in EBV-infected lymphoblastoid cells. Oncogene 17:1607–1615CrossRefPubMed Asso-Bonnet M, Feuillard J, Ferreira V, Bissières P, Tarantino N, Körner M, Raphael M (1998) Relationship between IkBα constitutive expression, TNFα synthesis, and apoptosis in EBV-infected lymphoblastoid cells. Oncogene 17:1607–1615CrossRefPubMed
29.
go back to reference Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G (1996) Association of TRAF1, TRAF2, and TRAF3 with an Epstein–Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kB activation. Mol Cell Biol 16:7098–7108CrossRefPubMedPubMedCentral Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G (1996) Association of TRAF1, TRAF2, and TRAF3 with an Epstein–Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kB activation. Mol Cell Biol 16:7098–7108CrossRefPubMedPubMedCentral
30.
go back to reference Thorley-Lawson DA (2001) Epstein–Barr virus: exploiting the immune system. Nat Rev Immunol 1:75–82CrossRefPubMed Thorley-Lawson DA (2001) Epstein–Barr virus: exploiting the immune system. Nat Rev Immunol 1:75–82CrossRefPubMed
31.
go back to reference Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dörken B (1996) High-level nuclear NF-kB and Oct-2 is a common feature of cultured Hodgkin/Reed–Sternberg cells. Blood 87:4340–4347PubMed Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dörken B (1996) High-level nuclear NF-kB and Oct-2 is a common feature of cultured Hodgkin/Reed–Sternberg cells. Blood 87:4340–4347PubMed
Metadata
Title
Changing patterns in the Epstein-Barr virus (EBV)and Hodgkin lymphoma association in Tunisia
Authors
Myriam Ben Dhiab
Sonia Ziadi
Hanene Saad
Teheni Louhichi
Mounir Trimeche
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2737-4

Other articles of this Issue 9/2016

Annals of Hematology 9/2016 Go to the issue